- Researchers tested a new antibody treatment in patients.
- It targets the blood cancer called multiple myeloma.
- The medicine has the name linvoseltamab.
- Doctors gave several treatment cycles to participants.
- Doctors used very sensitive bone marrow tests.
- The tests did not find cancer cells afterward.
- Some patients had low white blood cells.
- Serious immune reactions did not occur.
- Results are early but appear promising.
- The team will continue testing this treatment.
Difficult words
- antibody — A protein the immune system uses to fight germs
- multiple myeloma — A blood cancer that starts in bone marrow
- bone marrow — Soft tissue inside bones that makes blood cells
- white blood cell — A blood cell that helps fight infection and diseasewhite blood cells
- promising — Showing signs of future success or good results
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Related articles
T cells in tonsils differ from T cells in blood
A study found that T cells in the tonsils are different from T cells in blood. Researchers say doctors and scientists should study tissue T cells as well as blood to understand vaccines and immunotherapies.
Targeting inflammation as a way to treat depression
A federally funded review and meta-analysis found that anti-inflammatory treatments reduced depressive symptoms and eased anhedonia in people with depression who had high inflammation. The drugs were not FDA-approved for depression and would be used off-label.
January 2025 Los Angeles wildfires and the rise in virtual health visits
A study of 3.7 million Kaiser Permanente members found that the January 2025 Los Angeles wildfires caused large increases in virtual care, especially for respiratory and cardiovascular symptoms, and raised other outpatient visits.
Two types of microglia control anxiety in mice
Researchers at the University of Utah found two different microglia types in the brain that can cause or prevent anxiety in mice. The work suggests new ways to think about treatments, but therapies are not near-term.
New device measures blood viscosity in real time
Researchers at the University of Missouri created a non-invasive device that monitors blood viscosity and density in real time using ultrasound and software. It can read blood without drawing samples and may help in diseases like sickle cell.
New AI tools for tuberculosis shown at lung health conference
Researchers presented four new AI approaches for detecting and monitoring TB at the Union World Conference on Lung Health in Copenhagen (18–21 November). The tools include breath analysis, cough screening, vulnerability mapping and a chest X‑ray tool for children.